Synthetic Genomics Inc.
Industry
- Biotechnology
- Transgenics
- Drug Discovery Technologies
- Genomics-Proteomics
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Latest on Synthetic Genomics Inc.
Teresa Spehar, former vice president of intellectual property at Synthetic Genomics Inc. , has sued the company for gender discrimination against herself and other women working for the San Diego,
Sanofi has appointed Kathleen Tregoning a member of its executive committee and executive vice president, external affairs – effective Feb. 27, 2017. Tregoning joins Sanofi from Biogen Inc.
Over the last three decades, digital technologies have transformed lifestyles, livelihoods and businesses, creating new wealth, industrial sectors and opportunities. The impact of synthetic biology –
New At The Helm Company Changes AHUJA , Sanjeev, MD To: Celtaxsys Inc. , CMO (November) From: On Target Laboratories, CMO Phone: 415-829-7110 BAGAI , Shaun R. To: RenovoRx Inc. , CEO (Octo